MONDAY, April 25, 2022 (HealthDay News) — Two in five adults with attention-deficit/hyperactivity disorder say their mental health is excellent, which is significantly lower than people without the disorder, but still an encouraging finding, according to the authors of a new study. Their analysis of a Canadian government mental healthContinue Reading
WEDNESDAY, April 13, 2022 (HealthDay News) — Rates of gonorrhea are on the rise, and this sexually transmitted disease is becoming increasingly resistant to antibiotics, raising fears of a potential superbug. Luckily, while there isn’t a vaccine against gonorrhea yet, an available meningitis vaccine may offer some protection against thisContinue Reading
WEDNESDAY, April 13, 2022 (HealthDay News) — The more orgasms you have, the more you come to expect. And the reverse is also true, according to a new study of the so-called orgasm gap — in which men climax far more often than their female partners. “Our expectations are shapedContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — Even as the COVID-19 pandemic kept people isolated at home, sexually transmitted disease (STDs) cases increased across the United States. Although cases fell in the pandemic’s early months, infections rose again by the end of 2020, with gonorrhea, syphilis and congenital syphilis surpassingContinue Reading
MONDAY, April 11, 2022 (HealthDay News) — Catching COVID-19 appears to increase an older person’s risk of developing a case of shingles. Researchers found that people 50 and older who had a COVID infection were 15% more likely to develop shingles, compared to people who were never infected. That riskContinue Reading
THURSDAY, April 7, 2022 (HealthDay News) — The introduction of HAART (highly active anti-retroviral therapy) in the mid-1990s revolutionized the treatment of HIV/AIDS, halting disease progression and dramatically extending lives. Now, a small new study suggests another potential use for one of the standard HAART medications: It halted disease progressionContinue Reading
MONDAY, March 28, 2022 (HealthDay News) — Certain antiviral drugs used to treat HIV may also guard against COVID-19 infection, a new study suggests. The researchers found that people with HIV who are on antiretroviral treatment (ART) with protease inhibitors may have a lower risk of COVID-19 infection. Protease inhibitorsContinue Reading
TUESDAY, March 8, 2022 (HealthDay News) — There are serious mental harms and high financial costs associated with so-called conversion therapy for LGBTQ people, researchers report. Conversion therapy attempts to make lesbian, gay, bisexual, transgender and queer people “straight.” Its safety and effectiveness has been discredited in multiple prior studies.Continue Reading
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — The first condom specifically designed to prevent the transmission of HIV and other sexually transmitted infections during anal sex has been approved for sale in the United States, the U.S. Food and Drug Administration says. The One Male Condom can also be usedContinue Reading
WEDNESDAY, Feb. 16, 2022 (HealthDay News) — A woman with HIV who received an umbilical cord blood transplant has become the third person in the world to be cured of the virus that causes AIDS. The two others, both men, were cured after receiving bone marrow transplants from donors whoContinue Reading